Back
Viking Therapeutics Stock Predictions
![](/images/offers/ims/large/offer14.jpg)
Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
VKTX
Viking Therapeutics
Last Price:
$29.34
Seasonality Move:
26.12%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer13.jpg)
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Viking Therapeutics Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics has on average historically risen by 76% based on the past 9 years of stock performance.
-
Viking Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Viking Therapeutics Stock Undervalued?The current Viking Therapeutics [VKTX] share price is $29.96. The Score for VKTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics has on average historically risen by 76% based on the past 9 years of stock performance.
Viking Therapeutics Stock Rating
Sell
27
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics overpriced?
-
Viking Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Viking Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
99.41
52-Week Low:
29.08
Prediction Charts
Market Cap:
3.3B
Price in USD:
29.96
Volume:
4.7M
Beta:
1.26
Technical Analysis
SMA50:
40.29
SMA100:
51.75
SMA200:
56.06
52-Wk Change:
-2.03%
Stock Predictions
-
Is Viking Therapeutics stock public?Yes, Viking Therapeutics is a publicly traded company.
-
What is the Viking Therapeutics stock quote today?The Viking Therapeutics stock price is 29.96 USD today.
-
How to buy Viking Therapeutics stock online?You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-23 | 33.85 | 34.94 | 35.11 | 32.52 |
Jan-24 | 34.56 | 34.50 | 35.97 | 34.19 |
Jan-27 | 33.87 | 33.46 | 34.68 | 32.90 |
Jan-28 | 33.98 | 34.32 | 34.74 | 32.77 |
Jan-29 | 34.00 | 33.43 | 34.60 | 33.17 |
Jan-30 | 34.07 | 33.69 | 34.29 | 33.30 |
Jan-31 | 34.24 | 32.75 | 34.78 | 32.28 |
Feb-3 | 31.38 | 31.52 | 32.40 | 31.13 |
Feb-4 | 31.52 | 32.37 | 34.07 | 30.90 |
Feb-5 | 32.75 | 33.50 | 33.90 | 32.37 |
Feb-6 | 32.75 | 31.46 | 33.90 | 29.90 |
Feb-7 | 31.40 | 32.56 | 32.88 | 30.80 |
Feb-10 | 32.74 | 30.17 | 32.74 | 29.91 |
Feb-11 | 29.45 | 29.96 | 29.99 | 29.08 |
Viking Therapeutics Earnings
Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics Forecast Revenue Growth
Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.51 per share, and a decrease next year of $0.58 per share.
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.